Investments
155Portfolio Exits
39Funds
3About Lumira Ventures
Lumira Ventures collaborates with and invests in entrepreneurial management teams to build best-in-class, innovation-centric biotherapeutic and medical device companies that are meeting significant unmet needs and creating transformation impact in communities worldwide. Since 1989, Lumira Ventures has invested in over 100 healthcare companies and currently has a portfolio of 30+ active investee companies located in Canada and the United States.
Lumira Ventures Headquarter Location
141 Adelaide St. W. Ste. 770
Ontario, M5H 3L5,
Canada
416-213-4223
Lumira Ventures Web Traffic
Lumira Ventures Rank
Latest Lumira Ventures News
Jun 13, 2022
Corvia Medical, a Tewksbury, MA-based company dedicated to transforming the treatment of heart failure (HF), raised USD 54M in funding. Backers included Third Rock Ventures, General Catalyst Partners, AccelMed, Lumira Ventures, and Edwards Lifesciences.
Lumira Ventures Investments
155 Investments
Lumira Ventures has made 155 investments. Their latest investment was in Congruence Therapeutics as part of their Series A on February 2, 2022.
Lumira Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
2/8/2022 | Series A | Congruence Therapeutics | $50M | Yes | 7 | |
12/16/2021 | Seed VC | Specific Biologics | Yes | 1 | ||
12/8/2021 | Series B | OncoMyx | $50M | Yes | 17 | |
11/16/2021 | Series A | |||||
11/3/2021 | Series B - II |
Date | 2/8/2022 | 12/16/2021 | 12/8/2021 | 11/16/2021 | 11/3/2021 |
|---|---|---|---|---|---|
Round | Series A | Seed VC | Series B | Series A | Series B - II |
Company | Congruence Therapeutics | Specific Biologics | OncoMyx | ||
Amount | $50M | $50M | |||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 7 | 1 | 17 |
Lumira Ventures Portfolio Exits
39 Portfolio Exits
Lumira Ventures has 39 portfolio exits. Their latest portfolio exit was Bardy Diagnostics on August 06, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/6/2021 | Acquired | 15 | |||
6/5/2020 | Acquired | 6 | |||
9/13/2019 | IPO | Public | 3 | ||
Date | 8/6/2021 | 6/5/2020 | 9/13/2019 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 15 | 6 | 3 |
Lumira Ventures Fund History
3 Fund Histories
Lumira Ventures has 3 funds, including Lumira Capital IV.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
7/26/2021 | Lumira Capital IV | $220M | 5 | ||
Lumira Capital II | |||||
Merck-Lumira Biosciences Fund |
Closing Date | 7/26/2021 | ||
|---|---|---|---|
Fund | Lumira Capital IV | Lumira Capital II | Merck-Lumira Biosciences Fund |
Fund Type | |||
Status | |||
Amount | $220M | ||
Sources | 5 |
Lumira Ventures Team
6 Team Members
Lumira Ventures has 6 team members, including current Chief Financial Officer, Jacki Jenuth.
Name | Work History | Title | Status |
|---|---|---|---|
Jacki Jenuth | Chief Financial Officer | Current | |
Vasco Larcina | Enbridge Gas, and KPMG | Chief Financial Officer | Current |
Peter van der Velden | Canadian Venture Capital and Private Equity Association, MDS Capital, Fusion Capital, Taurus Capital, and Bedford Capital | Managing General Partner | Current |
Gerry Brunk | MDS Capital, ActiveCyte, The Boston Consulting Group, Credit Suisse First Boston, MAKO Surgical, and Vivre | Managing Director | Current |
Daniel Hetu | Managing Director | Current |
Name | Jacki Jenuth | Vasco Larcina | Peter van der Velden | Gerry Brunk | Daniel Hetu |
|---|---|---|---|---|---|
Work History | Enbridge Gas, and KPMG | Canadian Venture Capital and Private Equity Association, MDS Capital, Fusion Capital, Taurus Capital, and Bedford Capital | MDS Capital, ActiveCyte, The Boston Consulting Group, Credit Suisse First Boston, MAKO Surgical, and Vivre | ||
Title | Chief Financial Officer | Chief Financial Officer | Managing General Partner | Managing Director | Managing Director |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.